Heart failure drug changes the mechanoenzymology of the cardiac myosin powerstroke.

Heart failure drug changes the mechanoenzymology of the cardiac myosin powerstroke.

Item
http://www.wikidata.org/entity/Q41814795
Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light.Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil.Omecamtiv mercabil and blebbistatin modulate cardiac contractility by perturbing the regulatory state of the myosin filament.Allosteric modulation of cardiac myosin dynamics by omecamtiv mecarbil.A Cardiomyopathy Mutation in the Myosin Essential Light Chain Alters Actomyosin Structure.Do Actomyosin Single-Molecule Mechanics Data Predict Mechanics of Contracting Muscle?Positive cardiac inotrope omecamtiv mecarbil activates muscle despite suppressing the myosin working strokeControlling load-dependent kinetics of β-cardiac myosin at the single-molecule levelTargeting protein-protein interactions for therapeutic discovery via FRET-based high-throughput screening in living cellsActin-Myosin Interaction: Structure, Function and Drug Discovery
P2860

Heart failure drug changes the mechanoenzymology of the cardiac myosin powerstroke.

Item
http://www.wikidata.org/entity/Q41814795
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Heart failure drug changes the mechanoenzymology of the cardiac myosin powerstroke.
@en
type
label
Heart failure drug changes the mechanoenzymology of the cardiac myosin powerstroke.
@en
prefLabel
Heart failure drug changes the mechanoenzymology of the cardiac myosin powerstroke.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Heart failure drug changes the mechanoenzymology of the cardiac myosin powerstroke
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932